Skip to content

Clinical trials

Hypertension, Pulmonary trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Canada Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20053
20065
20071
20084
200912
20106
20112
20123
20131
20145
20153
20163
20173
20185
20194
20203
20216
20221
20235
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated22
Recruiting7
Active, not recruiting4
Unknown status3
Withdrawn3
Enrolling by invitation2
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer10
United Therapeutics7
Actelion5
Gilead Sciences5
University of Alberta5
GlaxoSmithKline3
Montreal Heart Institute3
Novartis Pharmaceuticals3
The Hospital for Sick Children3
University of Calgary3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary89
Pulmonary Arterial Hypertension31
Heart Failure6
Lung Diseases, Interstitial6
Lung Diseases5
Hypertension4
Pulmonary Disease, Chronic Obstructive4
Cardiovascular Diseases3
Connective Tissue Diseases3
Cystic Fibrosis3

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.